患者管理:中枢性性早熟
中枢性性早熟指女孩8岁前、男孩9岁前下丘脑-垂体-性腺轴提前激活。过去数十年乳房初发育年龄下降,但6-8岁乳房初发育女孩青春期进展速度可较慢且成年身高可能不受不利影响。超敏感黄体生成素检测和长效促性腺激素释放激素类似物的发展改善了诊疗,但缺乏精心设计的对照研究和明确实践指南,男孩数据有限,本文聚焦女孩尤其是6-8岁乳房初发育者。
要点
- 中枢性性早熟经典定义为女孩8岁前、男孩9岁前出现性发育。
- 6-8岁乳房初发育女孩青春期进展速度可较慢,成年身高可能不受不利影响。
- 超敏感黄体生成素检测减少了刺激试验需求,长效GnRHa制剂已应用于管理。
核心结论
- 中枢性性早熟的临床诊疗受限于缺乏精心设计的对照研究,管理决策常无明确实践指南支持,男孩数据有限,本文聚焦女孩尤其是6-8岁乳房初发育者的诊断与管理。
研究设计与样本
- 本文为患者管理综述,聚焦女孩中枢性性早熟的诊断与管理,尤其是6-8岁乳房初发育者。
主要发现
- 过去数十年乳房初发育年龄下降,但6-8岁乳房初发育女孩青春期进展速度可较慢,成年身高可能不受不利影响。
- 超敏感黄体生成素检测的广泛使用减少了刺激试验需求,并增进了对青春期启动遗传学的理解。
- 促性腺激素释放激素类似物(GnRHas)管理因新型长效制剂的问世而改变,关于肥胖、心血管危险因素和生育力的长期结局令人安心。
局限性
- 中枢性性早熟的临床诊疗受限于缺乏精心设计的对照研究,管理决策常无明确实践指南支持。
- 男孩中枢性性早熟数据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Central precocious puberty (CPP) classically refers to premature activation of the hypothalamic-pituitary-gonadal axis with onset of sexual development before the age of 8 years in girls and 9 years in boys. A decrease in the age of thelarche has been reported over the past several decades; however, the tempo of pubertal progression can be slower and adult height may not be adversely affected in many of the girls who experience thelarche at 6-8 years. Outside of this secular trend in the development itself, the past several decades have also brought about advances in diagnosis and management. This includes the widespread use of an ultrasensitive luteinizing hormone assay, decreasing the need for stimulation testing and a better understanding of the genetics that govern the onset of puberty. Additionally, management of CPP using gonadotropin-releasing hormone analogs (GnRHas) has changed with the advent of new longer-acting formulations. Emerging long-term outcomes of GnRHa administration with regards to obesity, cardiovascular risk factors and fertility are reassuring. Despite these advancements, clinical care in CPP is hampered by the lack of well-designed controlled studies, and management decisions are frequently not supported by clear practice guidelines. Data in boys with CPP are limited and this article focuses on the diagnosis and management of CPP in girls, particularly, in those who present with thelarche at the age of 6-8 years.
引用
- Kilberg MJ, Vogiatzi MG. Approach to the Patient: Central Precocious Puberty. J Clin Endocrinol Metab. 2023. PMID: 36916130. doi:10.1210/clinem/dgad081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。